Colossal Biosciences Raises $200 Million For De-Extinction Efforts
- Colossal Biosciences announced it raised $200 million in Series C financing, valuing the company at $10 billion, making it the first Texas startup to reach this valuation according to a spokesperson.
- The company aims to use gene editing to resurrect extinct animals to combat the extinction crisis, with around 27,000 species going extinct each year.
- Colossal plans to use the new funding to expand its team, develop new technologies, and enhance its de-extinction efforts, as stated by CEO Ben Lamm.
- TWG Global led the funding round, highlighting Colossal's role in advancing conservation and technology innovations in species preservation, according to CEO Mark Walter.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left2Leaning Right1Center4Last UpdatedBias Distribution57% Center
Bias Distribution
- 57% of the sources are Center
57% Center
L 29%
C 57%
14%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage